Economic evaluation guidelines in Latin America: A current snapshot

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 10, Issue 5, 2010, Pages 525-537

  Augustovski, Federico ^a,b,c   Garay, Osvaldo Ulises ^a   Pichon Riviere, Andres ^a,c   Rubinstein, Adolfo ^a,b,c   Caporale, Joaqun E ^a  

^a INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

economic evaluation of health technologies; guidelines; Latin America

Indexed keywords

ARTICLE; BRAZIL; COLOMBIA; COST EFFECTIVENESS ANALYSIS; CUBA; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; MEDLINE; MEXICO; PRACTICE GUIDELINE; RESOURCE MANAGEMENT; SOCIAL SECURITY; SOUTH AND CENTRAL AMERICA;

BIOMEDICAL TECHNOLOGY; DECISION MAKING; DEVELOPING COUNTRIES; EVALUATION STUDIES AS TOPIC; GUIDELINES AS TOPIC; HEALTH CARE COSTS; HUMANS; LATIN AMERICA; MODELS, ECONOMIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 77955787663     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.10.56     Document Type: Article

References (18)

1. Drummond M. Basic types of economic evaluation. In: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, New York, NY, USA, 7-27 (2005).
2. Office of Technology Assessment Advisory Committee. Development of Medical Technology: Opportunities for Assessment. United States of America Congress, Health Program Advisory Commitee, Washington, DC, USA (1976).
3. Harris A, Buxton M, O'Brien B et al. Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries. Expert Rev. Pharmacoeconomics Outcomes Res. 1(1), 7-12 (2001).
4. Taylor RS, Drummond MF, Salkeld G et al. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 329(7472), 972-975 (2004).
5. Hjelmgren J, Berggren F, Andersson F. Health economic guidelines - similarities, differences and some implications. Value Health 4(3), 225-250, (2001).
6. Kanavos P, Trueman P, Bosilevac A. Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal, The Netherlands, Finland, and the United Kingdom. Int. J. Technol. Assess. Health Care 16(4), 1179-1192 (2000).
7. McGuire A, Morris S, Raikou M. Where are the economic guidelines coming from? Int. J. Technol. Assess. Health Care 16(4), 976-986 (2000).
8. Walker D. Cost and cost-effectiveness guidelines: which ones to use? Health Policy Plan 16(1), 113-121 (2001).
9. Iglesias CP, Drummond MF, Rovira J. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int. J. Technol. Assess Health Care 21(1), 1-14 (2005).
10. Neto G. Utilizaçao de diretrizes nacionais e internacionais para execuçao da avaliaçao de tecnologias em saúde. In: Avaliaçao de Tecnologias em Saúde. Nita M (Ed.). Artmed, Porto Alegre, Brazil, 506-529 (2010).
11. Bertozzi S, Valencia Mendoza A, Hernández Garduño C et al. Guía Para la Conducción de Estudios de Evaluación Económica Para la Actualización del Cuadro Básico de Insumos del Sector Salud en México. Instituto Nacional de Salud Pública, Cuernavace, Mexico (2008).
12. Banta D, Almeida RT. The development of health technology assessment in Brazil. Int. J. Technol. Assess Health Care 25 (Suppl. 1), 255-259 (2009).
13. Lemgruber A. The role of HTA in the price regulation of new drugs: the Brazilian experience. Presented at: 4th International Symposium of Evidence-Based Health Care. Krakow, Poland, December 7-8 (2009).
14. Carrasquilla Gutiérrez G. Implementing pharmacoeconomic guidelines in evidence-based decision making in Latin America: lessons learned? Presented at: 2nd ISPOR Latin American Meeting. Rio de Janeiro, Brazil, September 10-12 (2009).
15. Gomez-Dantes O, Frenk J. Health technology assessment in Mexico. Int. J. Technol. Assess Health Care 25 (Suppl. 1), 270-275 (2009).
16. Mauskopf JA, Sullivan SD, Annemans L et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices-budget impact analysis. Value Health 10(5), 336-347 (2007).
17. Drummond MF, Schwartz JS, Jonsson B et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int. J. Technol. Assess Health Care 24(3), 244-258 (2008).
18. Rubinstein A, Fernández J, Gianneo O et al. Definition of Coverage Policies in the Context of Health Care Reform in Uruguay: Description of the Process and First Results. Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina (2008).